August 20, 2019
Leaning back on a black leather sofa as her campaign bus rumbled toward Fort Dodge, Kamala D. Harris tried to explain why she spent months defending a plan to replace private health insurance with Medicare-for-all, only to switch to a more modest proposal that would allow private insurance to continue after all. Read More
August 20, 2019
Between 2011 and 2017, Medicare could have saved $17.7 billion if generic versions of older medicines were prescribed instead of updated brand-name drugs launched by drugmakers to replace their older off-patent pills, according to a new study published in the Annals of Internal Medicine. Read More
August 20, 2019
Canadian health officials are expected to meet soon with their U.S. counterparts to detail major concerns over a proposal to set up drug importation. Read More
August 20, 2019
Fewer large, self-insured employers will offer a high-deductible health plan as the only employee insurance option next year, opting instead to give employees more choice when it comes to health coverage. Read More
August 20, 2019
Four in 10 privately insured patients faced surprise medical bills after visiting emergency rooms or getting admitted to hospitals in 2016, according to a new study published Monday in the American Medical Association's internal medicine journal. Read More
August 20, 2019
The American Medical Association (AMA), the nation’s main group for doctors, announced Thursday that it is leaving a coalition fighting "Medicare for All," a blow to the industry’s efforts to push back on the progressive proposal. Read More
August 20, 2019
The CMS announced Monday that it plans to change the controversial methodology used for its hospital star ratings in early 2021. Read More
August 20, 2019
A top Trump health administrator on Thursday said that officials are actively “working on” a plan to repeal and replace ObamaCare, which has remained a priority for President Trump even as many congressional Republicans look to move on. Read More
August 13, 2019
If health insurers have their way, Medicare for All will be a nonstarter. And they’ve got the lobbying battle lines drawn to prove it—with pharmaceutical companies on their side. Read More
August 13, 2019
Though support or opposition for “Medicare for All” is dominating the 2020 primary headlines, a large group of Americans is more ambivalent about the proposal, a new survey shows. Read More